TREATMENT OF EXTREMITY SOFT-TISSUE SARCOMAS WITH SURGERY AND RADIOTHERAPY

被引:49
作者
ROBINSON, M
BARR, L
FISHER, C
FRYATT, I
STOTTER, A
HARMER, C
WILTSHAW, E
WESTBURY, G
机构
[1] ROYAL MARSDEN HOSP,DEPT SURG,SARCOMA UNIT,LONDON SW3 6JJ,ENGLAND
[2] ROYAL MARSDEN HOSP,DEPT HISTOPATHOL,SARCOMA UNIT,LONDON SW3 6JJ,ENGLAND
[3] ROYAL MARSDEN HOSP,DEPT MED,SARCOMA UNIT,LONDON SW3 6JJ,ENGLAND
[4] ROYAL MARSDEN HOSP,DEPT COMP & STAT,SARCOMA UNIT,LONDON SW3 6JJ,ENGLAND
关键词
Extremity; Local control; Radiotherapy; Sarcoma; Surgery; Survival;
D O I
10.1016/0167-8140(90)90058-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The results of treatment with a combination of surgery and radiotherapy of 102 patients with non-metastatic extremity soft tissue sarcoma are reported. Seventy-nine patients were previously untreated and 23 had locally recurrent disease. Sixty-six tumours were situated in the lower limb and 16 in the limb girdles. Fifty-nine were high grade lesions, and 64 were over 5 cm in length. Surgical clearance was "good" (wide or radical) in only 34 cases. Sixty-eight patients received post-operative irradiation, 23 pre-operative irradiation and 11 both pre- and post-operative radiotherapy. Seventeen patients subsequently developed local recurrence and 9 of these remain disease-free after further surgery. Actuarial 5 year local control and disease-free survival rates for new cases were 87 and 65.4%; and for previously recurrent cases these figures fell to 75 and 54.8%. Following a univariate analysis of patient, tumour, surgical and radiotherapeutic factors only previous local recurrence (p < 0.1 > 0.05) was found to significantly increase the risk of further local relapse. Multivariate analysis found high tumour grade [relative risk (RR) 8.4], tumour size 15 cm (RR 3.66), previous local recurrence (RR 6.47) and proximal site (RR 12.7) to be independent poor risk factors for survival. © 1990.
引用
收藏
页码:221 / 233
页数:13
相关论文
共 28 条
[1]   RADIOTHERAPY AS AN INTEGRATED PART OF THE TREATMENT OF SOFT-TISSUE SARCOMAS [J].
ABBATUCCI, JS ;
BOULIER, N ;
DERANIERI, J ;
MANDARD, AM ;
TANGUY, A ;
BUSSON, A .
RADIOTHERAPY AND ONCOLOGY, 1984, 2 (02) :115-121
[2]   PRELIMINARY-RESULTS OF A RANDOMIZED TRIAL OF ADJUVANT DOXORUBICIN FOR SARCOMAS - LACK OF APPARENT DIFFERENCE BETWEEN TREATMENT GROUPS [J].
ANTMAN, K ;
SUIT, H ;
AMATO, D ;
CORSON, J ;
WOOD, W ;
PROPPE, K ;
HARMON, D ;
CAREY, R ;
GREENBERGER, J ;
BLUM, R ;
WILSON, R .
JOURNAL OF CLINICAL ONCOLOGY, 1984, 2 (06) :601-608
[3]   HYPOFRACTIONATED RADIOTHERAPY FOR SARCOMAS [J].
ASHBY, MA ;
AGO, CT ;
HARMER, CL .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1986, 12 (01) :13-17
[4]   TREATMENT OF SOFT-TISSUE SARCOMAS BY PREOPERATIVE IRRADIATION AND CONSERVATIVE SURGICAL RESECTION [J].
BARKLEY, HT ;
MARTIN, RG ;
ROMSDAHL, MM ;
LINDBERG, R ;
ZAGARS, GK .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1988, 14 (04) :693-699
[5]  
BRAMWELL V, 1988, DEV ONCOL, V55, P156
[6]  
BRENNAN MF, 1985, CANCER TREAT S, V3, P71
[7]   SOFT TISSUE TUMOURS - THEIR NATURAL HISTORY AND TREATMENT [J].
CADE, S .
PROCEEDINGS OF THE ROYAL SOCIETY OF MEDICINE-LONDON, 1951, 44 (01) :19-36
[8]  
CARABELL SC, 1981, SEMIN ONCOL, V8, P201
[9]   PROGNOSTIC FACTORS FOR LOCAL RECURRENCE AND SURVIVAL IN PATIENTS WITH LOCALIZED EXTREMITY SOFT-TISSUE SARCOMA [J].
COLLIN, CF ;
FRIEDRICH, C ;
GODBOLD, J ;
HAJDU, S ;
BRENNAN, MF .
SEMINARS IN SURGICAL ONCOLOGY, 1988, 4 (01) :30-37
[10]   A RANDOMIZED PROSPECTIVE TRIAL USING POSTOPERATIVE ADJUVANT CHEMOTHERAPY (ADRIAMYCIN) IN HIGH-GRADE EXTREMITY SOFT-TISSUE SARCOMA [J].
EILBER, FR ;
GIULIANO, AE ;
HUTH, JF ;
MORTON, DL .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1988, 11 (01) :39-45